斋月间歇性禁食与健康人群中抗凝剂活性改善有关:一项病例对照研究
1The Coagulation Research Laboratory, Physiology Department, College of Medicine and King Saud University Medical City, King Saud University, 11461, Riyadh, Saudi Arabia. aalghumlas@ksu.edu.sa.
Scientific reports
|June 15, 2024
概括
在健康人群中研究了斋月间歇性禁食 (RIF). 禁食增加了蛋白S的水平,这是一种天然抗凝剂,可能会提供对血栓的保护.
科学领域:
- 生理学 生理学 生理学
- 血液学 血液学 血液学
- 营养 营养 营养 营养 营养
背景情况:
- 关于斋月间歇性禁食 (RIF) 期间的静血变化存在有限的数据.
- 了解RIF期间天然凝血抑制剂的变化对于评估血栓形成风险至关重要.
研究的目的:
- 评估RIF对天然抗凝剂的影响:抗血素,蛋白C和总和自由蛋白S (PS).
主要方法:
- 对比了29名健康的禁食参与者的凝血参数与40名健康的非禁食对照.
- 评估的抗血素,蛋白C,总/自由PS,C4结合蛋白 (C4BP),前血素时间 (PT),激活的部分血栓塑时间 (APTT) 和纤维素原水平.
主要成果:
- 禁食组的总和自由蛋白S水平显著更高 (p < 0.05).
- 在抗血素,蛋白C或C4BP水平上没有发现显著变化.
- 禁食组的纤维素水平升高,而PT和APTT保持不变.
结论:
- RIF与增强的抗凝剂活性有关,特别是增加了蛋白S水平.
- 在RIF期间发生的这些静血变化可能会在健康人群中提供暂时的生理保护,防止血栓形成.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
57
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
57
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
968
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
968
Metabolic States of the Body: Fasting and Starvation
1.3K
During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...
1.3K
Dipeptidyl Peptidase 4 Inhibitors
181
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
181


